MiniMed Group Inc. Common Stock vs Vanguard Growth Index Fund ETF — how do they compare? MiniMed Group Inc. Common Stock trades at $19.57 (market cap $5.57B), while Vanguard Growth Index Fund ETF trades at $91.92 (market cap $384.60B). The key difference: Vanguard Growth Index Fund ETF is far larger — about 69× MiniMed Group Inc. Common Stock's market cap, and Vanguard Growth Index Fund ETF is trading nearer its 52-week high, MiniMed Group Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold MiniMed Group Inc. Common Stock for 0 Days and Vanguard Growth Index Fund ETF for 47 Days on average.
| MMED | VUG | |
|---|---|---|
Market Cap | $5.57B | $384.60B |
Volume | 23,336,073 | 5,662,307 |
Sector | Health | Sector/Thematic |
52-Week High | $23.84 | $92.64 |
52-Week Low | $10.80 | $70.00 |
Typical Hold Time | 0 Days | 47 Days |
Enterprise Value | $5.37B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VUG trades at $92.42, down 0.24% on the day, with a bullish technical outlook supported by moving averages but showing overbought conditions on shorter-term RSI readings. The ETF maintains strong long-term performance credentials with 11-12% average annual returns since 2004, though current concentration in mega-cap tech stocks presents both opportunity and risk. Recent dividend activity shows minimal income generation with a $0.09 distribution scheduled for September 2026.
The growth-focused ETF offers exposure to market-leading companies but faces concentration risk with over 36% in three holdings. Long-term investors benefit from Vanguard's low-cost structure and historical outperformance, though near-term technical indicators suggest potential consolidation. Market sentiment remains positive for buy-and-hold strategies despite recent value stock outperformance in 2026.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
MiniMed develops, manufactures, and markets diabetes-management technologies. Its products include insulin-delivery systems, continuous glucose monitors, smart insulin pens, and related software.
Read more on MMED →VUG is an index-based ETF that tracks the CRSP US Large Cap Growth Index, providing concentrated exposure to the largest and fastest-growing companies in the United States. It focuses on stocks with high growth potential across tech, communication, and consumer sectors, serving as a low-cost, high-conviction core holding for long-term capital appreciation.
Read more on VUG →